IV iron dextran is most cost-effective, yielding 19.26 QALYs compared with 19.10 QALYs for oral ferrous sulfate ...

Intravenous (IV) iron therapy is more effective than oral drugs for women with anemia and heavy periods, providing better ...

Dextran is a medication used for the management and treatment of various medical conditions such as surgical procedures, shock, hemorrhage, radiological imaging, ophthalmic relief of xerophthalmia, ...

A single dose of intravenous (IV) iron dextran is the cost-effective treatment for women with heavy menstrual bleeding and ...

October 16, 2009 — Anaphylactic reactions, including fatalities, have been reported after parenteral administration of iron dextran injection (Dexferrum), the US Food and Drug Administration (FDA) and ...

Review the side-effects of Iron Dextran as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

Following the Federal Trade Commission's approval to add iron dextran to the banned substances list under the Horseracing Integrity and Safety Authority's (HISA) Anti-Doping and Medication Control ...

While the risk of anaphylaxis after administration of IV iron product was low among older adults, it was more common after certain iron products, researchers found. The highest adjusted incidence ...

The oliguria persisted for twenty-two days, and the patient required 3 hemodialyses before entering the diuretic phase. Subsequently we have been able to reproduce acute anuria after the ...

It’s no secret that women are underrepresented in the realm of U.S. patent holders. A briefing paper released last summer by the Institute for Women’s Policy Research (IWPR) indicated that less than ...

The patient was initially seen at the age of 5 months for neutropenia. He was diagnosed with Kostmann syndrome, displaying severe neutropenia, immature myeloid hyperplasia with maturation arrest on ...

Before iron was used as an adjunct to erythropoietic stimulatory therapy in patients undergoing hemodialysis, parenteral iron was considered to be dangerous. High-molecular-weight iron dextran ...